Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting
- PMID: 31597431
- DOI: 10.1021/acs.nanolett.9b02841
Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting
Abstract
Using natural membranes to coat nanoparticles (NPs) provides an efficient means to reduce the immune clearance of NPs and improve their tumor-specific targeting. However, fabrication of these drug-loaded biomimetic NPs, such as exosome membrane (EM)- or cancer cell membrane (CCM)-coated poly(lactic-co-glycolic acid) (PLGA) NPs, remains a challenging task owing to the heterogeneous nature of biomembranes and labor-intensive procedures. Herein, we report a microfluidic sonication approach to produce EM-, CCM-, and lipid-coated PLGA NPs encapsulated with imaging agents in a one-step and straightforward manner. Tumor cell-derived EM-coated PLGA NPs consisting of both endosomal and plasma membrane proteins show superior homotypic targeting as compared to CCM-PLGA NPs of similar sizes and core-shell structures in both in vitro and in vivo models. The underlying mechanism is associated with a significantly reduced uptake of EM-PLGA NPs by macrophages and peripheral blood monocytes, revealing an immune evasion-mediated targeting of EM-PLGA NPs to homologous tumors. Overall, this work illustrates the promise of using microfluidic sonication approach to fabricate biomimetic NPs for better biocompatibility and targeting efficacy.
Keywords: Microfluidics; biomimetic nanoparticles; exosomes; immune evasion; targeting.
Similar articles
-
Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.Int J Nanomedicine. 2022 Feb 22;17:837-854. doi: 10.2147/IJN.S346685. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35228800 Free PMC article.
-
Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.Int J Nanomedicine. 2018 Aug 31;13:4961-4975. doi: 10.2147/IJN.S170148. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30214200 Free PMC article.
-
Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.J Nanobiotechnology. 2015 Apr 3;13:29. doi: 10.1186/s12951-015-0088-2. J Nanobiotechnology. 2015. PMID: 25888948 Free PMC article.
-
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.Acta Biomater. 2020 Aug;112:1-13. doi: 10.1016/j.actbio.2020.05.028. Epub 2020 May 26. Acta Biomater. 2020. PMID: 32470527 Review.
-
Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications.Bioeng Transl Med. 2022 Nov 2;8(2):e10441. doi: 10.1002/btm2.10441. eCollection 2023 Mar. Bioeng Transl Med. 2022. PMID: 36925703 Free PMC article. Review.
Cited by
-
Biomimetic nanovesicle design for cardiac tissue repair.Nanomedicine (Lond). 2020 Aug;15(19):1873-1896. doi: 10.2217/nnm-2020-0097. Epub 2020 Aug 5. Nanomedicine (Lond). 2020. PMID: 32752925 Free PMC article.
-
Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment.Theranostics. 2022 Jan 16;12(4):1683-1714. doi: 10.7150/thno.67775. eCollection 2022. Theranostics. 2022. PMID: 35198064 Free PMC article. Review.
-
Microfluidic synthesis of fibronectin-coated polydopamine nanocomplexes for self-supplementing tumor microenvironment regulation and MR imaging-guided chemo-chemodynamic-immune therapy.Mater Today Bio. 2023 May 18;20:100670. doi: 10.1016/j.mtbio.2023.100670. eCollection 2023 Jun. Mater Today Bio. 2023. PMID: 37251416 Free PMC article.
-
Biomimetic Nanoparticles for Basic Drug Delivery.Pharmaceutics. 2024 Oct 7;16(10):1306. doi: 10.3390/pharmaceutics16101306. Pharmaceutics. 2024. PMID: 39458635 Free PMC article. Review.
-
Recent advances in surface modification of micro- and nano-scale biomaterials with biological membranes and biomolecules.Front Bioeng Biotechnol. 2022 Oct 12;10:972790. doi: 10.3389/fbioe.2022.972790. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36312538 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources